GeXP多重基因表达遗传分析系统在手足口病病原分型检测中的应用

利用GeXP多重基因表达遗传分析系统,建立一种多重逆转录-聚合酶链反应(RT-PCR)方法,同时检测引起手足口病的9种常见的人肠道病毒—人肠道病毒71型(HEV71)、柯萨奇病毒A组(CVA)16、4、5、9、10型和柯萨奇病毒B组(CVB)1、3、5型。优化多重反应体系中针对5’UTR区的肠道病毒通用引物和11对针对9种血清型人肠道病毒VP1区的特异性引物的浓度比例,分别以病毒细胞培养物和阳性粪便标本来验证多重反应体系的特异性,以TCID50定量的细胞培养物和克隆质粒体外转录的RNA梯度稀释液来检测多重检测体系的灵敏度。结果表明,优化后的多重检测体系,可扩增出人肠道病毒共有的保守片段的和型特异性片段,HEV71和CVA16细胞培养物的检测下限为100.5TCID50/μL,并可在103copies/μL水平同时、特异地检测出9种病毒RNA。该方法灵敏度高、特异性强,可快速对大量临床样本进行高通量检测,用于手足口病的分子流行病学调查。     

五种主要上呼吸道病毒多重RT-PCR 检测方法的建立

目的:建立甲型、乙型流感病毒、呼吸道合胞病毒A型、B型(RSV-A、RSV-B)和腺病毒(ADV)五种主要上呼吸道病毒的多重RT-PCR检测方法。方法:利用Primer premier5.0分别针对甲型流感病毒的M基因、乙型流感病毒的PB1基因、RSV-A和RSV-B的F基因及ADV的hexon基因设计五对特异性引物,对Mg2+、dNTP、引物浓度及退火温度等进行优化,建立同时检测甲型、乙型流感病毒、RSV-A、RSV-B和ADV的多重RT-PCR方法,并验证该检测方法的灵敏性。结果:所建立的五种病毒的多重RT-PCR方法可以同时或者分别扩增甲型、乙型流感病毒、RSV-A、RSV-B及ADV的141bp、635bp、525bp、377b和283bp基因片段,敏感度分别达到770PFU/ml、800PFU/ml、680PFU/ml、970PFU/ml和850PFU/ml,且五种病毒间无交叉反应。结论:所建立的多重RT-PCR方法可以迅速准确地检测甲型、乙型流感病毒、RSV-A、RSV-B和ADV,为五种病毒的检测提供了一种方便易行的方法。     

同时检测新甲型H1N1及人季节性H1N1和H3N2流感病毒的单管多重荧光定量PCR方法

本研究设计的一种4重荧光定量RT-PCR检测方法,以A型流感病毒各亚型的血凝素基因(HA)为检测靶标,实现了同时检测新甲型H1N1流感病毒、人季节性H1N1流感病毒和人季节性H3N2流感病毒。本法使用人细胞RNA酶P基因作为内参,以判断标本来源和实施质量控制。利用不同来源和亚型的流感病毒验证了该方法的特异性;利用连续稀释的新甲型H1N1流感病毒HA全基因体外转录物进行灵敏度分析。结果表明该方法灵敏度高,可检测低至20个拷贝的RNA;特异性强,每对引物只检测出对应的病毒,无交叉反应;并且成功地验证性检验了34份新甲型H1N1流感病毒阳性临床标本和20份人季节性H1N1和H3N2流感病毒及人乙型(HB)流感病毒阳性临床标本。因此,该多重荧光定量RT-PCR法是一种可同时检测2009年新甲型流感病毒及季节性流感病毒的有效方法。     

七重呼吸道病毒液相芯片核酸检测技术的初步建立

由呼吸道病毒引起的疾病严重威胁着人类的生命健康，为了建立一种快速高通量的呼吸道病毒核酸检测方法，本研究将多重PCR技术同液相芯片技术结合起来，针对呼吸道合胞病毒A型和B型、乙型流感病毒Victoria系和Yamagata系、甲型流感病毒H1型和H3型以及新冠病毒等常见的七种呼吸道病毒，初步建立了七重呼吸道病毒液相芯片核酸检测技术，评价了方法的特异性、敏感性和重复性，并使用来自安徽省疾控的25份临床急性期样本核酸对方法进行验证。结果显示，建立起的基于液相芯片多重核酸检测方法可特异性识别七种目标呼吸道病毒的靶基因序列，与包括副流感病毒在内的9种非目标呼吸道病毒无交叉反应。对七种病毒核酸进行十倍稀释液相检测，其中H3、BV、RSVB可以检出10²拷贝/μL,BY、RSVA和SARS-CoV-2可以检出10³拷贝/μL，对H1的检测限为10⁴拷贝/μL。25份样本核酸检测结果与实际相符。结果表明，本研究建立的七重呼吸道病毒液相芯片核酸检测技术具有特异性强、敏感性高、稳定性好等特点，可用于临床样本的快速检测，为呼吸道类传染病的液相...     

8种脑炎相关虫媒病毒GeXP检测方法的初步建立

利用GeXP多重基因表达遗传分析系统,建立一种多重逆转录-聚合酶链反应(mRT-PCR)方法,同时检测与病毒性脑炎相关的乙型脑炎病毒(Japanese encephalitis virus,JEV)等8种虫媒病毒。优化多重反应体系及反应条件,分别以病毒分离培养物和阳性标本来验证多重反应体系的特异性,以克隆质粒体外转录的RNA梯度稀释液来检测多重检测体系的灵敏度。结果表明,优化后的多重检测体系,可扩增出各病毒对应的特异片段,并可在102拷贝/μL水平同时并特异地检测出8种(共13个特异片段)脑炎相关病毒RNA。该方法具有高通量、灵敏度高、特异性强且快速等优点,对病毒性脑炎的分子诊断及流行病学调查具有重要意义。     

同时鉴别6种鸡病毒性呼吸道病GeXP检测方法的建立

为了建立一种能够同时鉴别H5、H7、H9亚型禽流感、新城疫、传染性支气管炎和传染性喉气管炎6种鸡病毒性呼吸道传染病病原体的GeXP检测方法,本研究根据这些病原体各自的基因保守序列,设计合成了7对特异性引物,优化反应条件,用单一病毒、混合病毒样品来验证所建立的GeXP方法的特异性和准确性,以不同拷贝数的克隆质粒来检测GeXP方法的灵敏度。检测34份临床阳性样品,进一步验证该法的可靠性。结果显示,在7对引物同时存在的GeXP反应体系中,可特异性地扩增出相关6种病毒目的片段,并可在102拷贝/μL水平同时特异地检测出鸡6种病毒性呼吸道传染病,GeXP方法检测34份临床阳性样品结果与病毒分离一致。本研究建立的GeXP方法不仅可高通量检测6种病原体,而且具有特异性强和灵敏度高的特点,适用于临床样品混合感染的快速鉴别诊断,对这6种发病特征及临床症状相似的鸡病毒性呼吸道病的有效防控有很高的实际应用价值。     

荧光定量RT-PCR技术快速检测SARS病毒核酸

建立以特异性荧光探针为特点的TaqMan荧光定量RT-PCR方法用于检测严重急性呼吸道综合症病毒(severe acute respiratory syndrome -associate coronavirus,SARS-CoV)核酸.筛选针对SARS病毒基因保守区域设计的引物与TaqMan探针,并对荧光定量RT-PCR反应体系与反应条件进行优化,验证本方法的特异性、敏感度与重复性. 实验结果表明本方法对SARS病毒核酸的检测具有高度特异性,与甲1型、甲3型、乙型流感病毒、禽流感病毒H5N1、麻疹及其他呼吸道病毒均无交叉反应;检测灵敏度达0.1TCID50;从病毒核酸提取至检测完成仅需3h左右,且操作简便,重复性好.本研究建立的TaqMan荧光定量RT-PCR方法特异、敏感、快速,适合于临床实验室进行SARS病毒的早期快速检测.     

9种呼吸道病毒微流体芯片检测体系构建与应用

近年来,越来越多新的致病性呼吸道病毒被发现,给口岸检验检疫机构的预防和控制造了成极大困扰,建立甲型流感病毒(Influenza A virus,FluA)、乙型流感病毒(Influenza B virus,FluB)、副流感病毒(Human Parainfluenza virus,HPIV)、冠状病毒(Coronavirus,Cov)、呼吸道合胞病毒(Respiratory syncytial virus,RSV)、人偏肺病毒(Humanmetapneumovirus,HMPV)、人博卡病毒(Human bocavirus,Hbov)、腺病毒(Adenovirus,Adv)和鼻病毒(Rhinovirus,Rhv)9种呼吸道病原体微流体芯片检测体系。选择人β-actin基因作为靶基因设计内标引物探针,根据9种呼吸道病原体基因组的保守区设计相应的引物探针;在Ultra Fast Labchip Real-time PCR V280平台上,筛选合适的RT-PCR Master Mix;对扩增体系中引物探针浓度进行优化,用优化后的扩增体系进行灵敏度和特异性验证;用100例临床标本进行回顾性检测。选出具有快速扩增性能的RT-PCR Master Mix,优化后病原体上游引物、下游引物和探针终浓度分别为500nmol/L、500nmol/L和250nmol/L,内标基因上游引物、下游引物和探针终浓度均为300nmol/L、300nmol/L和150nmol/L;在此扩增体系下,9种呼吸道病毒的最低检测限均为1.0×10~3拷贝/mL,不同病毒无交叉反应,对100例临床样本检测,准确率100%。因此,本研究建立了一种可同时用于9种呼吸道病毒快速检测的微流体芯片扩增体系,采用本检测体系可在25min内实现上述9种病毒核酸定性检测。     

Analytical Sensitivity Comparison between Singleplex Real-Time PCR and a Multiplex PCR Platform for Detecting Respiratory Viruses

Multiplex PCR methods are attractive to clinical laboratories wanting to broaden their detection of respiratory viral pathogens in clinical specimens. However, multiplexed assays must be well optimized to retain or improve upon the analytic sensitivity of their singleplex counterparts. In this experiment, the lower limit of detection (LOD) of singleplex real-time PCR assays targeting respiratory viruses is compared to an equivalent panel on a multiplex PCR platform, the GenMark eSensor RVP. LODs were measured for each singleplex real-time PCR assay and expressed as the lowest copy number detected 95–100% of the time, depending on the assay. The GenMark eSensor RVP LODs were obtained by converting the TCID₅₀/mL concentrations reported in the package insert to copies/μL using qPCR. Analytical sensitivity between the two methods varied from 1.2–1280.8 copies/μL (0.08–3.11 log differences) for all 12 assays compared. Assays targeting influenza A/H3N2, influenza A/H1N1pdm09, influenza B, and human parainfluenza 1 and 2 were most comparable (1.2–8.4 copies/μL, <1 log difference). Largest differences in LOD were demonstrated for assays targeting adenovirus group E, respiratory syncytial virus subtype A, and a generic assay for all influenza A viruses regardless of subtype (319.4–1280.8 copies/μL, 2.50–3.11 log difference). The multiplex PCR platform, the GenMark eSensor RVP, demonstrated improved analytical sensitivity for detecting influenza A/H3 viruses, influenza B virus, human parainfluenza virus 2, and human rhinovirus (1.6–94.8 copies/μL, 0.20–1.98 logs). Broader detection of influenza A/H3 viruses was demonstrated by the GenMark eSensor RVP. The relationship between TCID₅₀/mL concentrations and the corresponding copy number related to various ATCC cultures is also reported.     

Respiratory virus multiplex RT-PCR assay sensitivities and influence factors in hospitalized children with lower respiratory tract infections

Multiplex RT-PCR assays have been widely used tools for detection and differentiation of a panel of respiratory viral pathogens. In this study, we evaluated the Qiagen ResPlex II V2.0 kit and explored factors influencing its sensitivity. Nasopharyngeal swab (NPS) specimens were prospectively collected from pediatric inpatients with lower respiratory tract infections at the time of admission in the Shenzhen Children’s Hospital from May 2009 to April 2010. Total nucleic acids were extracted using the EZ1 system (Qiagen, Germany) and 17 respiratory viruses and genotypes including influenza A virus (FluA), FluB, parainfluenza virus 1 (PIV1), PIV2, PIV3, PIV4, respiratory syncytial virus (RSV), human metapneumovirus (hMPV), rhinoviruses (RhV), enteroviruses (EnV), human bocaviruses (hBoV), adenoviruses (AdV), four coronaviruses (229E, OC43, NL63 and HKU1), and FluA 2009 pandemic H1N1(H1N1-p) were detected and identified by the ResPlex II kit. In parallel, 16 real-time TaqMan quantitative RT-PCR assays were used to quantitatively detect each virus except for RhV. Influenza and parainfluenza viral cultures were also performed. Among the total 438 NPS specimens collected during the study period, one or more viral pathogens were detected in 274 (62.6%) and 201(45.9%) specimens by monoplex TaqMan RT-PCR and multiplex ResPlex, respectively. When results from monoplex PCR or cell culture were used as the reference standard, the multiplex PCR possessed specificities of 92.9–100.0%. The sensitivity of multiplex PCR for PIV3, hMPV, PIV1 and BoV were 73.1%, 70%, 66.7% and 55.6%, respectively, while low sensitivities (11.1%–40.0%) were observed for FluA, EnV, OC43, RSV and H1N1. Among the seven viruses/genotypes detected with higher frequencies, multiplex PCR sensitivities were correlated significantly with viral loads determined by the TaqMan RT-PCR in FluA, H1N1-p and RSV (p=0.011?0.000). The Qiagen ResPlex II multiplex RT-PCR kit possesses excellent specificity for simultaneous detection of 17 viral pathogens in NPS specimens in pediatric inpatients at the time of admission. The sensitivity of multiplex RT-PCR was influenced by viral loads, specimen process methods, primer and probe design and amplification condition.     

Development of multiplex rt-PCR assays for rapid detection and subtyping of influenza type A viruses from clinical specimens

We developed multiplex RT-PCR assays that can detect and identify 12 hemagglutinin (H1-H12) and 9 neuraminidase (N1-N9) subtypes that are commonly isolated from avian, swine, and human influenza A viruses. RT-PCR products with unique sizes characteristic of each subtype were amplified by multiplex RT-PCRs, and sequence analysis of each amplicon was demonstrated to be specific for each subtype with 24 reference viruses. The specificity was demonstrated further with DNA or cDNA templates from 7 viruses, 5 bacteria, and 50 influenza A virus negative specimens. Furthermore, the assays could detect and subtype up to 105 dilution of each of the reference viruses that had an original infectivity titer of 106 EID50/ml. Of 188 virus isolates, the multiplex RT-PCR results agreed completely with individual RT-PCR subtyping results and with results obtained from virus isolations. Furthermore, the multiplex RT-PCR methods efficiently detected mixed infections with at least two different subtypes of influenza viruses in one host. Therefore, these methods could facilitate rapid and accurate subtyping of influenza A viruses directly from field specimens.     

High Incidence of Multiple Viral Infections Identified in Upper Respiratory Tract Infected Children under Three Years of Age in Shanghai, China

Background

Upper respiratory tract infection (URTI) is a major reason for hospitalization in childhood. More than 80% of URTIs are viral. Etiological diagnosis of URTIs is important to make correct clinical decisions on treatment methods. However, data for viral spectrum of URTIs are very limited in Shanghai children.

Methods

Nasopharyngeal swabs were collected from a group of 164 children aged below 3 years who were hospitalized due to acute respiratory infection from May 2009 to July 2010 in Shanghai. A VRDAL multiplex PCR for 10 common respiratory viruses was performed on collected specimens compared with the Seeplex® RV15 ACE Detection kit for 15 respiratory viruses.

Results

Viruses were detected in 84 (51.2%) patients by VRDAL multiplex PCR, and 8 (4.9%) of cases were mixed infections. Using the Seeplex® RV15 ACE Detection kit, viruses were detected in 129 (78.7%) patients, 49 (29.9%) were co-infected cases. Identified viruses included 37 of human rhinovirus (22.6% of cases), 32 of influenza A virus (19.5%), 30 of parainfluenzavirus-2 (18.3%), 23 of parainfluenzavirus-3 (14.0%), 15 of human enterovirus (9.1%), 14 each of parainfluenzavirus-1, respiratory syncytial virus B and adenovirus (8.5%), 8 of coronavirus 229E/NL63 (4.9%), 6 of human bocavirus (3.7%), 5 each of influenza B virus and respiratory syncytial virus A (3.0%), 3 of parainfluenzavirus-4 (1.8%), 2 of coronavirus OC43/HKU1 (1.2%), and 1 human metapneumovirus (0.6%).

Conclusions

A high frequency of respiratory infections (78.7%) and co-infections (29.9%) was detected in children with acute respiratory infection symptoms in Shanghai. The Seeplex® RV15 ACE detection method was found to be a more reliable high throughput tool than VRDAL method to simultaneously detect multiple respiratory viruses.     

Studies on the epidemiology of child infections. 3. Parainfluenza viruses (types 1-4) and respiratory syncytial virus infections.

A seroepidemiological study on the rate of neutralizing antibodies for parainfluenza viruses (types 1-4) and for the respiratory syncytial virus in 2,514 infants and children between 0 and 15 years, residing in Bari and its hinterland was carried out. Positive results were very high for both the individual parainfluenza serotypes (81.7% for type 3, 78.0% for type 1, 76.6% for type 4, 71.9% for type 2) and for respiratory syncytial virus (88.5%). The pattern of infections due to respiratory syncytial virus differed from that of the parainfluenza viruses not only for the higher serologic positive rate, but also for the larger number of elevated titre responses in each age group.